aldesulfone 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
antimycobacterials, diaminodiphenylsulfone derivatives 2533 144-75-2

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • aldesulfone sodium
  • aldapsone
  • sodium aldesulphone
  • aldesulfone
  • sodium sulfoxone
  • sulfoxone sodium
  • sulfoxone
  • diasone sodium
  • Molecular weight: 404.47
  • Formula: C14H16N2O6S3
  • CLOGP: -1.21
  • LIPINSKI: 0
  • HAC: 8
  • HDO: 4
  • TPSA: 132.80
  • ALOGS: -2.19
  • ROTB: 8
  • Status: OFM
    • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

DoseUnitRoute
0.33 g O

ADMET properties:

PropertyValueReference
MRTD (Maximum Recommended Therapeutic Daily Dose) 12.36 µM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
kinase-safety-class ACVR2A,ACVR2B,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EGFR,EIF2AK3,EPHB4,ERBB2,GRK2,GRK3,GSK3B,IKBKB,ITK,JAK2,JAK3,MAP2K6,MAP3K21,MAP3K7,MAPK10,MAPK12,MAPK14,MAPK7,MAPK9,MAPKAPK2,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CB,PIM2,PLK1,PRKDC,SIK2,SIK3,STK33,SYK,TEK,TGFBR1,TTK,ZAP70 50
kinase-selectivity-class AURKA,GRK2,MAP2K6,MAPK7,PDK2,PDK4,TEK 7
pfas-class PFAS structural alert (1 = True, 0 = False) 0

Approvals:

DateAgencyCompanyOrphan
May 24, 1974 FDA ABBVIE

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC J04BA03 ANTIINFECTIVES FOR SYSTEMIC USE
ANTIMYCOBACTERIALS
DRUGS FOR TREATMENT OF LEPRA
Drugs for treatment of lepra
CHEBI has role CHEBI:35816 leprostatic drug

Related Drugs by ATC class:

J04BA Drugs for treatment of lepra 3 drugs
clofaziminedapsonerifampicin

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 2.5 acidic
pKa2 3.1 acidic
pKa3 4.06 Basic
pKa4 3.46 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])		Mechanism
action		Bioact sourceMoA source
Glucose-6-phosphate 1-dehydrogenase Enzyme WOMBAT-PK
Dihydropteroate synthase 1 Enzyme INHIBITOR CHEMBL CHEMBL

External reference:

IDSource
D02521 KEGG_DRUG
144-76-3 SECONDARY_CAS_RN
C0075606 UMLSCUI
CHEBI:748891 CHEBI
CHEMBL1570 ChEMBL_ID
CHEMBL1200580 ChEMBL_ID
DB01145 DRUGBANK_ID
C036115 MESH_SUPPLEMENTAL_RECORD_UI
5351 PUBCHEM_CID
003005 NDDF
004972 NDDF
91266006 SNOMEDCT_US
971 INN_ID
57OWB0Q221 UNII

Pharmaceutical products:

None